Administration of Migraine Injection | AJOVY® (fremanezumab-vfrm) injection
Teva's AJOVY Approved for Migraine Prevention
Teva to Present Data at the 2023 American Headache Society Annual Scientific Meeting Demonstrating AJOVY® (fremanezumab-vfrm) Injection Significantly Reduced Migraine and Depression Symptoms in Patients